29.04.2024
Б. С. Белов; В. S. Belov; Н. В. Муравьева; Е. Л. Насонов; Е. L. Nasonov
. Significant progress was made during the COVID-19 pandemic due to the dynamic development of vaccine research
29.02.2024
Е. Л. Насонов
The pandemic of coronavirus disease 2019 (COVID-19), etiologically related to the SARS-CoV-2 virus
27.10.2023
Е. Л. Насонов; А. С. Авдеева; Т. М. Решетняк; А. П. Алексанкин; Ю. П. Рубцов
and fibrosis in immunemediated rheumatic diseases (IMRD), malignant neoplasms, atherosclerosis, COVID-19
31.08.2023
Б. С. Белов; Е. С. Аронова; Г. И. Гриднева; Е. Л. Насонов
During the three years that have passed since the beginning of the COVID-19 pandemic, many new
28.06.2023
А. А. Баранов; И. Б. Виноградова; О. Н. Аношенкова; О. В. Антипова; Е. А. Богданова; Ю. Ю. Грабовецкая; Е. П. Иливанова; А. Н. Калягин; И. Н. Кушнир; Н. А. Лапкина; М. В. Мокроусова; О. Б. Несмеянова; Н. М. Никитина; П. А. Шестерня; Н. В. Юдина; Е. Л. Насонов
in the context of the COVID-19 pandemic, such switching occurred for non-medical reasons as well. However
01.03.2023
Б. С. Белов; Е. Л. Насонов
high. During the development of the COVID-19 pandemic, which has become a challenge to all mankind
17.01.2023
З. Н. Сукмарова; В. Б. Симоненко; Е. Л. Насонов
structures associated with COVID-19. A literature review has been carried out with the use of the medical
30.11.2022
З. Н. Сукмарова; Ф. М. Ибрагимова; О. М. Ларина; А. И. Громов; Е. Л. Насонов
During the pandemic COVID-19, there has been an increase in the number of patients with non
01.07.2022
Е. Л. Насонов; М. Ю. Самсонов
14.05.2022
Е. Л. Насонов; А. С. Авдеева
Interleukin 18 in Immune-mediated rheumatic diseases and COVID-19
